Back

Lipid lowering therapy and the unmet targets in Indian patients with angiographically proven coronary artery disease: results from the OLS registry

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Lipids as risk factors for cardiovascular disease Drug therapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kunal Mahajan

Himachal Heart Institute, Himachal Pradesh (India)

8 More presentations in this session

Presentation thumbnail
Physician disagreement with treatment guidelines as a critical barrier to achieving low-density lipoprotein cholesterol targets in very high-risk patients: an implementation science study
Associate Professor K. Cho (Gwangju, KR)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) and atherosclerotic cardiovascular disease in a Brazilian tertiary hospital population
Doctor V. Zorzanelli Rocha (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Impact of glucose metabolism status on the relationship between remnant cholesterol and ischemic risk after percutaneous coronary intervention: a large-scale long-term cohort study from real-world
Doctor K. Yan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Association between lipoprotein particle concentration and size and progression of coronary plaque: the MACS Longitudinal Coronary CT angiography study
Doctor R. Quispe (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
The association of inflammation, triglycerides and lipoprotein(a) with cardiovascular events in the UK Biobank
Doctor B. Tucker (Sydney, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids as risk factors for cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Suboptimal LDL-C control despite high statin use: insights from the LAI-LCARE survey on secondary CAD prevention in India
thumbnail
Congress Presentation
Unmet needs of LDL C lowering in ACS patients when using only high intensity statins puts at setback
thumbnail
Congress Presentation
Efficacy of combination lipid lowering therapy in achieving low density lipoprotein cholesterol targets after one month of event in patients with acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources